Company intelligence / Profile preview

ConAlliance

Ownership: Private
Development stage: Other

Overview

ConAlliance is a leading advisory firm focused solely on mergers and acquisitions in the global healthcare sector, providing bespoke M&A, licensing, and strategic advisory services for companies and assets across life science, pharma, biotech, devices, and services industries[2].

Industry: Consulting

Partnerships

BBS-Bioactive Bone Substitutes: Strategic financing and corporate development agreement[5]Cambridge Respiratory Innovations Limited (CRiL): Strategic development and commercial advisory[3]

Beyond the preview

Go deeper on ConAlliance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ConAlliance.

Explore the full profile